FRESH-PEF138-en
Persistence of evidence-based medical therapies over time in patients monitored by cardiologists after a first recent ACS
PREVENIR 4
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data']
Individuals
| Topic | Vocabulary |
|---|---|
| Cardiology and vascular medicine | health theme |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"M/F >=18 years, outpatient seen in cardiology consultation, hospitalized in 2005 for a first ACS","clusion_E":""}
| Name |
|---|
| Elisabeth;AMELINEAU |
| Nathalie;SCHMIDELY |
| Name | Role |
|---|---|
| BRISTOL MYERS SQUIBB PHARMA FRANCE S.A | sponsor |
| Name |
|---|
| BRISTOL MYERS SQUIBB PHARMA FRANCE S.A |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Probability.Cluster","vocab":"CESSDA"},"value":"Probability: Cluster"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2006-01-01 | 2007-01-01 |
One-time cross-sectional study
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}